Summary
Two new cytotoxic norditerpene dilactones, milanjilactones A(3) and B(4) have been isolated from the stem bark ofPodocarpus milanjianus Rendle and characterized, on the basis of spectroscopic evidence, as 1,2-dehydro derivatives of nagilactones F(1) and G(2).
Similar content being viewed by others
References
For a recent review see S. Ho and M. Kodams, Heterocycles4, 595 (1976).
J.A. Hembree, C.-J. Chang, J.L. McLaughlin, J.M. Cassady, D.J. Watts, E. Wenkert, S.F. Fonseca and J. de Paiva Campello, Phytochemistry18, 1691 (1979).
R.I. Geran, N.H. Greenberg, M.M. MacDonald, A.A. Schumacher and B.J. Abbott, Cancer Chemother. Rep.3, 3 (1972). Cytotoxicity was assayed under the auspices of contract NO1-CM-62091 awarded by the Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland awarded for support of this work.
Y. Hayashi, J. Yokoi, Y. Watanabe, T. Sakan, Y. Masuda and R. Yamamoto, Chem. Lett.1972, 759.
M.N. Galbraith, D.H.S. Horn and J.M. Sasse, Chem. Commun.1971, 1362.
S.M. Kupchan, R.L. Baxter, M.G. Ziegler, P.M. Smith and R.F. Bryan, Experientia31, 137 (1975).
S. Ito and M. Kodama, Heterocycles4, 595 (1976).
Author information
Authors and Affiliations
Additional information
The authors acknowledge the technical assistance of Ms Teresa K. Lightner. Part 11 in the series ‘Potential Antitumor Agents’.
Rights and permissions
About this article
Cite this article
Hembree, J.A., Chang, Cj., McLaughlin, J.L. et al. Milanjilactones A and B, two novel cytotoxic norditerpene dilactones fromPodocarpus milanjianus Rendle. Experientia 36, 28–29 (1980). https://doi.org/10.1007/BF02003950
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02003950